{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:25:09Z","timestamp":1795008309530,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s41030-023-00226-y","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T06:02:20Z","timestamp":1684562540000},"page":"295-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Post-COVID-19 Pulmonary Fibrosis: Facts\u2014Challenges and Futures: A Narrative Review"],"prefix":"10.1007","volume":"9","author":[{"given":"Sy","family":"Duong-Quy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu","family":"Vo-Pham-Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh","family":"Tran-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Huynh-Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinh","family":"Vo-Van","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Vu-Tran-Thien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8358-902X","authenticated-orcid":false,"given":"Vinh","family":"Nguyen-Nhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"3","key":"226_CR1","first-page":"e22770","volume":"14","author":"A Mohammadi","year":"2022","unstructured":"Mohammadi A, Balan I, Yadav S, et\u00a0al. Post-COVID-19 pulmonary fibrosis. Cureus. 2022;14(3):e22770.","journal-title":"Cureus"},{"key":"226_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y, et\u00a0al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220\u201332.","journal-title":"Lancet"},{"key":"226_CR3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0194-2021","volume":"30","author":"RJ Mylvaganam","year":"2021","unstructured":"Mylvaganam RJ, Bailey JI, Sznajder JI, et\u00a0al. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev. 2021;30: 210194.","journal-title":"Eur Respir Rev"},{"key":"226_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, et\u00a0al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601\u201315.","journal-title":"Nat Med"},{"issue":"1","key":"226_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12931-022-02163-x","volume":"23","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yim JJ, Park J. Pulmonary function and chest computed tomography abnormalities 6\u201312 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23(1):233. https:\/\/doi.org\/10.1186\/s12931-022-02163-x. (Published 2022 Sep 6).","journal-title":"Respir Res"},{"issue":"3","key":"226_CR6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jmv.27399","volume":"94","author":"G d'Ettorre","year":"2022","unstructured":"d\u2019Ettorre G, Gentilini Cacciola E, Santinelli L, et\u00a0al. Covid-19 sequelae in working age patients: a systematic review. J Med Virol. 2022;94(3):858\u201368. https:\/\/doi.org\/10.1002\/jmv.27399.","journal-title":"J Med Virol"},{"issue":"11","key":"226_CR7","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.3390\/ijms22116151","volume":"22","author":"A Mongelli","year":"2021","unstructured":"Mongelli A, Barbi V, Gottardi Zamperla M, et\u00a0al. Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors. Int J Mol Sci. 2021;22(11):6151. https:\/\/doi.org\/10.3390\/ijms22116151. (Published 2021 Jun 7).","journal-title":"Int J Mol Sci"},{"issue":"3","key":"226_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijtb.2020.11.003","volume":"68","author":"DK Rai","year":"2021","unstructured":"Rai DK, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis. Is it real threat? Indian J Tuberc. 2021;68(3):330\u20133. https:\/\/doi.org\/10.1016\/j.ijtb.2020.11.003.","journal-title":"Indian J Tuberc"},{"key":"226_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et\u00a0al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4: e2128568.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"226_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med. 2020;180(7):934\u201343.","journal-title":"China JAMA Intern Med"},{"issue":"1","key":"226_CR11","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1016\/j.jinf.2020.04.008","volume":"81","author":"X Liu","year":"2020","unstructured":"Liu X, Zhou H, Zhou Y. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J Infect. 2020;81(1):e95\u20137.","journal-title":"J Infect"},{"key":"226_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/17476348.2021.1916472","volume":"15","author":"SE Tanni","year":"2021","unstructured":"Tanni SE, Fabro AT, de Albuquerque A, Machado Ferreira EV, Verrastro CGY, Sawamura MVY, et\u00a0al. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expet Rev Respir Med. 2021;15:791\u2013803.","journal-title":"Expet Rev Respir Med"},{"key":"226_CR13","first-page":"1","volume":"20","author":"B Oronsky","year":"2021","unstructured":"Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, et\u00a0al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2021;20:1\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"key":"226_CR14","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.3906\/sag-2106-238","volume":"51","author":"D Esenda\u011fli","year":"2021","unstructured":"Esenda\u011fli D. Post-COVID syndrome: pulmonary complications. Turk J Med Sci. 2021;51:3359\u201371.","journal-title":"Turk J Med Sci"},{"key":"226_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.36142","volume":"4","author":"M Bellan","year":"2021","unstructured":"Bellan M, Soddu D, Balbo PE, et\u00a0al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4: e2036142.","journal-title":"JAMA Netw Open"},{"key":"226_CR16","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1513\/AnnalsATS.202012-1489RL","volume":"18","author":"SJ Abdallah","year":"2021","unstructured":"Abdallah SJ, Voduc N, Corrales-Medina VF, et\u00a0al. Pulmonary function and functional capacity four months after COVID-19. Ann Am Thorac Soc. 2021;18:1912\u20137.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"226_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1515\/cclm-2021-1021","volume":"60","author":"Vianello","year":"2022","unstructured":"Vianello, et\u00a0al. Pulmonary fibrosis in COVID-19 survivors. Clin Chem Lab Med. 2022;60(3):307\u201316.","journal-title":"Clin Chem Lab Med"},{"key":"226_CR18","first-page":"2557","volume":"20","author":"E Vasarmidi","year":"2020","unstructured":"Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N, Antoniou KM. Pulmonary fibrosis in the aftermath of the COVID-19 era. Exp Ther Med. 2020;20:2557\u201360.","journal-title":"Exp Ther Med"},{"key":"226_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1183\/09031936.00196412","volume":"43","author":"EL Burnham","year":"2014","unstructured":"Burnham EL, Janssen WJ, Riches DWH, et\u00a0al. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J. 2014;43:276\u201385.","journal-title":"Eur Respir J"},{"key":"226_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00134-007-0964-9","volume":"34","author":"P Pelosi","year":"2008","unstructured":"Pelosi P, Rocco PR. Effects of mechanical ventilation on the extracellular matrix. Intensive Care Med. 2008;34:631\u20139.","journal-title":"Intensive Care Med"},{"key":"226_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41392-020-00355-9","volume":"5","author":"L Leng","year":"2020","unstructured":"Leng L, Cao R, Ma J, et\u00a0al. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020;5:240. https:\/\/doi.org\/10.1038\/s41392-020-00355-9.","journal-title":"Signal Transduct Target Ther"},{"key":"226_CR22","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1177\/2047487320932695","volume":"27","author":"F Gentile","year":"2020","unstructured":"Gentile F, Aimo A, Forfori F, et\u00a0al. COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead. Eur J Prev Cardiol. 2020;27:1442\u20136. https:\/\/doi.org\/10.1177\/2047487320932695.","journal-title":"Eur J Prev Cardiol"},{"key":"226_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/imr.12977","volume":"302","author":"AE John","year":"2021","unstructured":"John AE. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts. Immunol Rev. 2021;302:228\u201340.","journal-title":"Immunol Rev"},{"key":"226_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/thoraxjnl-2020-215314","volume":"75","author":"PM George","year":"2020","unstructured":"George PM, Barratt SL, Condliffe R, et\u00a0al. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020;75:1009\u201316.","journal-title":"Thorax"},{"key":"226_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.pulmoe.2020.10.013","volume":"27","author":"R Torres-Castro","year":"2021","unstructured":"Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et\u00a0al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021;27:328\u201337.","journal-title":"Pulmonology"},{"key":"226_CR26","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211396","volume":"301","author":"JJ Solomon","year":"2021","unstructured":"Solomon JJ, Heyman B, Ko JP, et\u00a0al. CT of postacute lung complications of COVID-19. Radiology. 2021;301: 211396.","journal-title":"Radiology"},{"key":"226_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00174-0","author":"X Wu","year":"2021","unstructured":"Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et\u00a0al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021. https:\/\/doi.org\/10.1016\/S2213-2600(21)00174-0. (published online ahead of print, 2021 May 5).","journal-title":"Lancet Respir Med"},{"issue":"1","key":"226_CR28","doi-asserted-by":"publisher","first-page":"E177","DOI":"10.1148\/radiol.2021203153","volume":"299","author":"X Han","year":"2021","unstructured":"Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et\u00a0al. Six-month follow- up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299(1):E177\u201386. https:\/\/doi.org\/10.1148\/radiol.2021203153.","journal-title":"Radiology"},{"key":"226_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.rx.2021.02.003","volume":"63","author":"J Alarc\u00f3n-Rodr\u00edguez","year":"2021","unstructured":"Alarc\u00f3n-Rodr\u00edguez J, Fern\u00e1ndez-Velilla M, Ure\u00f1a-Vacas A, et\u00a0al. Radiological management and follow-up of post-COVID-19 patients. Radiologia. 2021;63:258.","journal-title":"Radiologia"},{"key":"226_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/thoraxjnl-2020-215818","volume":"76","author":"S Mandal","year":"2021","unstructured":"Mandal S, Barnett J, Brill SE, et\u00a0al. \u201cLong-COVID\u201d: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396\u20138.","journal-title":"Thorax"},{"key":"226_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217031","author":"CF McGroder","year":"2021","unstructured":"McGroder CF, Zhang D, Choudhury MA, Salvatore MM, D\u2019Souza BM, Hoffman EA, et\u00a0al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leukocyte telomere length. Thorax. 2021. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217031. (published online ahead of print, 2021 Apr 29).","journal-title":"Thorax"},{"key":"226_CR32","first-page":"00655","volume":"7","author":"R D\u2019Cruz","year":"2021","unstructured":"D\u2019Cruz R, Waller M, Perrin F, et\u00a0al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7:00655\u20132020.","journal-title":"ERJ Open Res"},{"issue":"4","key":"226_CR33","volume":"47","author":"BG Baldi","year":"2021","unstructured":"Baldi BG, Tanni SE. Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification. J Bras Pneumol. 2021;47(4): e20210213.","journal-title":"J Bras Pneumol"},{"issue":"4","key":"226_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249607","volume":"16","author":"DT Arnold","year":"2021","unstructured":"Arnold DT, Donald C, Lyon M, Hamilton FW, Morley AJ, Attwood M, et\u00a0al. Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks. PLoS\u00a0One. 2021;16(4): e0249607. https:\/\/doi.org\/10.1371\/journal.pone.0249607.","journal-title":"PLoS\u00a0One"},{"key":"226_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244114","volume":"15","author":"UW Ko","year":"2020","unstructured":"Ko UW, Cho EJ, Oh HB, Koo HJ, Do KH, Song JW. Serum Krebs von den Lungen-6 level predicts disease progression in interstitial lung disease. PLoS\u00a0One. 2020;15: e0244114. https:\/\/doi.org\/10.1371\/journal.pone.0244114.","journal-title":"PLoS\u00a0One"},{"key":"226_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2021.02.012","volume":"517","author":"DH Peng","year":"2021","unstructured":"Peng DH, Luo Y, Huang LJ, et\u00a0al. Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019. Clin Chim Acta. 2021;517:48\u201353. https:\/\/doi.org\/10.1016\/j.cca.2021.02.012.","journal-title":"Clin Chim Acta"},{"key":"226_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.chest.2020.03.037","volume":"158","author":"Y Inoue","year":"2020","unstructured":"Inoue Y, Kaner RJ, Guiot J, et\u00a0al. Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases wth a progressive phenotype. Chest. 2020;158:646\u201359. https:\/\/doi.org\/10.1016\/j.chest.2020.03.037.","journal-title":"Chest"},{"key":"226_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8:807\u201315.","journal-title":"Lancet Respir Med"},{"key":"226_CR39","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s10787-022-01027-6","volume":"30","author":"HM Al-kuraishy","year":"2022","unstructured":"Al-kuraishy HM, Batiha GE-S, Faidah H, Al-Gareeb AI, Saad HM, Simal-Gandara J. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology. 2022;30:2017\u201326.","journal-title":"Inflammopharmacology"},{"key":"226_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12931-018-0907-8","volume":"19","author":"HY Yoon","year":"2018","unstructured":"Yoon HY, Park S, Kim DS, Song JW. Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis. Respir Res. 2018;19:203.","journal-title":"Respir Res"},{"issue":"9","key":"226_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4149\/BLL_2022_105","volume":"123","author":"B Kerget","year":"2022","unstructured":"Kerget B, CIL G, Araz O, Alper F, Akgun M. When and how important is anti-fibrotic therapy in the postCOVID-19 period? Bratisl Med J. 2022;123(9):653\u20138.","journal-title":"Bratisl Med J"},{"key":"226_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/thoraxjnl-2020-216088","volume":"76","author":"I Vad\u00e1sz","year":"2021","unstructured":"Vad\u00e1sz I, Husain-Syed F, Dorfm\u00fcller P, et\u00a0al. Severe organising pneumonia following COVID-19. Thorax. 2021;76:201\u20134.","journal-title":"Thorax"},{"key":"226_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000724","volume":"7","author":"P Kory","year":"2020","unstructured":"Kory P, Kanne JP. SARS-CoV-2 organising pneumonia: \u201cHas there been a widespread failure to identify and treat this prevalent condition in COVID-19?\u201d BMJ Open Respir Res. 2020;7: e000724.","journal-title":"BMJ Open Respir Res"},{"key":"226_CR44","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra2005230","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med. 2020;383:958\u201368.","journal-title":"N Engl J Med"},{"key":"226_CR45","doi-asserted-by":"publisher","first-page":"n136","DOI":"10.1136\/bmj.n136","volume":"372","author":"W Shah","year":"2021","unstructured":"Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. https:\/\/doi.org\/10.1136\/bmj.n136.","journal-title":"BMJ"},{"key":"226_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmed.2020.00539","volume":"7","author":"S Chaudhary","year":"2020","unstructured":"Chaudhary S, Natt B, Bime C, Knox KS, Glassberg MK. Antifibrotics in COVID-19 lung disease: let us stay focused. Front Med (Lausanne). 2020;7:539. https:\/\/doi.org\/10.3389\/fmed.2020.00539.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"226_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/cmrp.cmrp_110_21","volume":"12","author":"M Tanvir","year":"2022","unstructured":"Tanvir M, Wagay I, Nisar S, Ahmed RN, Maqbool M, Kareem O, Muzaffer U. 2022 Early intervention with anti-fibrotic pirfenidone is effective than corticosteroids in preventing pulmonary fibrosis in severe COVID pneumonia patients. Curr Med Res Pract. 2022;12(2):53. https:\/\/doi.org\/10.4103\/cmrp.cmrp_110_21.","journal-title":"Curr Med Res Pract"},{"key":"226_CR48","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.apmr.2021.03.035","volume":"102","author":"S Reina-Guti\u00e9rrez","year":"2021","unstructured":"Reina-Guti\u00e9rrez S, Torres-Costoso A, Mart\u00ednez-Vizca\u00edno V, de Arenas-Arroyo SN, Fern\u00e1ndez-Rodr\u00edguez R, Pozuelo-Carrascosa DP. Effectiveness of pulmonary rehabilitation in interstitial lung disease, including coronavirus diseases: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2021;102:1989-97.e3. https:\/\/doi.org\/10.1016\/j.apmr.2021.03.035.","journal-title":"Arch Phys Med Rehabil"},{"key":"226_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.physio.2021.01.007","volume":"111","author":"VA Goodwin","year":"2021","unstructured":"Goodwin VA, Allan L, Bethel A, et\u00a0al. Rehabilitation to enable recovery from COVID-19: a rapid systematic review. Physiotherapy. 2021;111:4\u201322. https:\/\/doi.org\/10.1016\/j.physio.2021.01.007.","journal-title":"Physiotherapy"},{"key":"226_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1183\/09059180.00001811","volume":"20","author":"JJ Egan","year":"2011","unstructured":"Egan JJ. Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient. Eur Respir Rev. 2011;20:114\u20137. https:\/\/doi.org\/10.1183\/09059180.00001811.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"226_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s41030-022-00188-7","volume":"8","author":"S Duong-Quy","year":"2022","unstructured":"Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Thi-Kim T, Nguyen-Quang T, Nguyen-Chi T, Nguyen-Thi-Y N, Duong-Thi-Thanh V, Ngo C, Craig T. The use of therapeutic plasma exchange in the treatment of a pregnant woman with COVID-19 induced acute respiratory distress syndrome. Pulmonary Therapy. 2022;8(2):233\u201340.","journal-title":"Pulmonary Therapy"},{"key":"226_CR52","first-page":"1","volume":"24","author":"S Duong-Quy","year":"2022","unstructured":"Duong-Quy S, Huynh-Truong-Anh D, Le-Thi-Hong N, Le-Van T, Le-Thi-Kim S, Nguyen-Quang T, Nguyen-Thi-Kim T, Nguyen-Phuong N, Nguyen-Chi T, Nguyen-Van T, Duong-Thi-Thanh V. Acute respiratory distress syndrome associated with multisystem inflammatory syndrome in a child with Covid-19 and diabetic ketoacidosis: a case report. Pulm Ther. 2022;24:1.","journal-title":"Pulm Ther"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-023-00226-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-023-00226-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-023-00226-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:20:36Z","timestamp":1692807636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-023-00226-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["226"],"URL":"https:\/\/doi.org\/10.1007\/s41030-023-00226-y","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}